“I consider that number to be quite poor,” Dr. Still, only 42.4% of people 65 and older-and 16.7% of all eligible people in the U.S.-have gotten the first bivalent shot, according to the CDC. have been in people 50 and older, and the numbers increase with age, according to CDC data. What’s more, the vast majority of the more than 1.1 million deaths from COVID-19 in the U.S.
Studies have shown that COVID-19 vaccines can prevent COVID-related hospitalization and death. “I support the booster for those who are eligible and want to get it,” says Yale Medicine infectious diseases specialist Scott Roberts, MD. The bivalent boosters are available from both Pfizer-BioNTech and Moderna.
This booster is identical to the reformulated, or "bivalent," booster introduced in fall 2022 in that it targets two virus strains: Omicron subvariants BA.4 and BA.5 and the original SARS-CoV-2 virus. Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) are offering a second bivalent booster shot. Those two groups are more likely than others to get severely ill or die from COVID-19-that’s why the U.S. The number of cases of COVID-19 may be dropping, but the disease is still a concern for those who are 65 and older (more than 53 million people in the United States) and those with weak immune systems (about 7 million people).
0 kommentar(er)
